Insufficient scRNA-seq data for expression of PMS2P1 at single-cell level.
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 342.09 | 180 / 180 | 100% | 10.69 | 430 / 430 |
| brain | 100% | 336.27 | 2639 / 2642 | 100% | 8.60 | 705 / 705 |
| breast | 100% | 479.58 | 459 / 459 | 100% | 8.69 | 1116 / 1118 |
| prostate | 100% | 349.70 | 245 / 245 | 100% | 6.76 | 500 / 502 |
| uterus | 100% | 328.26 | 170 / 170 | 100% | 6.26 | 457 / 459 |
| esophagus | 100% | 269.96 | 1445 / 1445 | 99% | 6.14 | 182 / 183 |
| thymus | 100% | 408.09 | 653 / 653 | 99% | 7.12 | 601 / 605 |
| lung | 100% | 272.77 | 576 / 578 | 99% | 6.80 | 1149 / 1155 |
| skin | 100% | 362.41 | 1807 / 1809 | 99% | 8.40 | 468 / 472 |
| bladder | 100% | 340.86 | 21 / 21 | 99% | 6.60 | 499 / 504 |
| stomach | 100% | 196.52 | 359 / 359 | 99% | 5.34 | 283 / 286 |
| liver | 100% | 240.71 | 226 / 226 | 99% | 5.22 | 401 / 406 |
| kidney | 100% | 480.57 | 89 / 89 | 98% | 6.16 | 885 / 901 |
| intestine | 100% | 280.49 | 966 / 966 | 97% | 5.51 | 512 / 527 |
| adrenal gland | 100% | 358.53 | 258 / 258 | 93% | 5.52 | 215 / 230 |
| pancreas | 91% | 105.94 | 298 / 328 | 97% | 5.02 | 172 / 178 |
| adipose | 100% | 426.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 16.23 | 29 / 29 |
| spleen | 100% | 468.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 4.87 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.61 | 1 / 1 |
| blood vessel | 100% | 312.36 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 222.21 | 798 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 5.21 | 79 / 80 |
| heart | 98% | 244.20 | 841 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 383.30 | 874 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006298 | Biological process | mismatch repair |
| GO_0032300 | Cellular component | mismatch repair complex |
| GO_0016301 | Molecular function | kinase activity |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0140664 | Molecular function | ATP-dependent DNA damage sensor activity |
| Gene name | PMS2P1 |
| Protein name | Putative postmeiotic segregation increased 2-like protein 1 (PMS2-related protein 2) (Postmeiotic segregation increased 2-like protein 13) (Postmeiotic segregation increased 2-like protein 6) (Postmeiotic segregation increased 2-like protein 8) (Postmeiotic segregation increased protein 3) (hPMS3) (Postmeiotic segregation increased protein 8) (Putative postmeiotic segregation increased 2 pseudogene 1) |
| Synonyms | PMS2L1 PMS8 PMS2L6 PMS2L8 PMS3 PMS2L13 PMSR2 |
| Description | |
| Accessions | A4D2B8 |